Bone Morphogenetic Proteins
- Name
- Bone Morphogenetic Proteins
- Accession Number
- DBCAT002859
- Description
Bone-growth regulatory factors that are members of the transforming growth factor-beta superfamily of proteins. They are synthesized as large precursor molecules which are cleaved by proteolytic enzymes. The active form can consist of a dimer of two identical proteins or a heterodimer of two related bone morphogenetic proteins.
- ATC Classification
- Drugs
Drug Drug Description Dibotermin alfa indicated for the treatment of acute tibia fractures in adults, as an adjunct to standard care using open fracture reduction and intramedullary unreamed nail fixation [FDA Label]. indicated for single-level... Eptotermin alfa A bone morphogenetic protein that is widely expressed during EMBRYONIC DEVELOPMENT. It is both a potent osteogenic factor and a specific regulator of nephrogenesis. Eptotermin alfa is an ingredient in... - Drugs & Drug Targets
Drug Target Type Dibotermin alfa Bone morphogenetic protein receptor type-1A target Dibotermin alfa Bone morphogenetic protein receptor type-2 target